MMIT - Managed Markets Insight & Technology

16/11/2025

One Platform. One Experience. All of MMIT. ✔️

Introducing the MMIT Platform. This platform serves as a digital front door to access MMIT solutions, capabilities, and data.

Gain access to everything you need, all in one place. https://vist.ly/4eq79

MMIT’s Platform is a strategic leap forward—built to streamline how commercialization teams access insights, execute workflows, and make decisions.

16/11/2025

Need help driving revenue with real-world data solutions? Take it from our clients – we’ve got the expertise to help. Let’s talk. https://vist.ly/4epve

16/11/2025

https://vist.ly/4eptu | The exponential growth of the 340B Drug Pricing Program has contributed to its many challenges, including duplicative payments. MMIT’s discusses manufacturers’ efforts to legalize a rebate model and shares provider sentiment about a potential shift.

15/11/2025

At MMIT, we understand that policies can frequently change and that each change can be crucial. https://vist.ly/4engx

Our new policy alerting support tool, Searchlight, now displays the history of policy changes and each historical document, enabling your team to view the complete picture of each relevant policy. Learn more about MMIT's Searchlight at the link in this post.

15/11/2025

https://vist.ly/4en46 | You can’t make confident access decisions without complete data. MMIT Analytics provides the most comprehensive view of formulary coverage, medical policies, and restriction information. Use it to evaluate patient access for your brand and your competitors. Sharper insights lead to better decisions. Learn more at the link in this post.

14/11/2025

https://vist.ly/4eiqu | Alternative funding programs (AFPs) promise short-term savings—but at what cost?

MMIT’s shares the latest research on how payers and employers view AFPs, along with tips for how pharma companies can safeguard their PAPs and educate patients about AFP practices.

14/11/2025

The correlation between payer policy, prescribing behavior, and patient outcomes isn’t always easy to prove. https://vist.ly/4eibh

In this case study, learn how one pharma company used unstructured EMR data to show payers the care delays caused by restrictions and prior authorizations—which resulted in policy revisions.

14/11/2025

Use Case Download: Discover how MMIT, powered by NorstellaLinQ, is redefining rare disease targeting through real-world data. https://vist.ly/4ef2b

13/11/2025

Please be aware that unauthorized job postings have appeared on LinkedIn claiming to represent MMIT. For accurate information on open roles, visit norstella.com/careers.

If you believe you’ve been impacted, email ApplicationHelp@norstella.com.

13/11/2025

Have you experienced the MMIT Platform yet?

The MMIT Platform provides a single point of entry, enabling customers to engage with solutions, data, and insights tailored to their individual needs, helping them build and execute a customized strategy. This platform serves as a digital front door to access MMIT solutions, capabilities, and data.

Learn more: https://vist.ly/4e7jz

MMIT’s Platform is a strategic leap forward—built to streamline how commercialization teams access insights, execute workflows, and make decisions.

13/11/2025

What if you could access the most comprehensive rare disease insights in one place? https://vist.ly/4e7ju

Our new exclusive content hub brings together expert perspectives, data-driven analysis, and stories that matter—designed for those shaping the future of rare disease care. Explore what you’ve been missing at the link in this post.

12/11/2025

Therapies with excellent coverage don’t always have excellent patient access. https://vist.ly/4e3rp

Learn how one pharma company tracked down the reason for its brand’s rejected and abandoned claims using MMIT’s Analytics with integrated real-world data signals.